Aanjaneya Lifecare debuted on the National Stock Exchange today. The pharma company listed at Rs 218 as against the issue price of Rs 234. It touched an intraday high of Rs 274.95 and an intraday low of Rs 218. The company raised around Rs 120 crore through the issue of 50 lakh equity shares at higher end of price band of Rs 228-240 a share.
Aanjaneya is a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments. Kannan K Vishwanath, VC and MD, Aanjaneya Lifecare talks to CNBC-TV18 about the latest happenings in his company and what the road ahead looked like. Below is a verbatim transcript of his interview with CNBC-TV18Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
